Cargando…
Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial
The present trial aimed to investigate the effects of pioglitazone on the serum level of asymmetric dimethylarginine (ADMA), a marker of endothelial function, and some indices of inflammation and glucose and lipid metabolism in nondiabetic metabolic syndrome patients. 104 eligible participants (57%...
Autores principales: | Shokouh, Pedram, Joharimoghadam, Adel, Roohafza, Hamidreza, Sadeghi, Masoumeh, Golabchi, Allahyar, Boshtam, Maryam, Sarrafzadegan, Nizal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654334/ https://www.ncbi.nlm.nih.gov/pubmed/23710164 http://dx.doi.org/10.1155/2013/358074 |
Ejemplares similares
-
A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial
por: Roohafza, Hamidreza, et al.
Publicado: (2014) -
Relationship between Metabolic Syndrome and Its Components with Psychological Distress
por: Roohafza, Hamidreza, et al.
Publicado: (2014) -
Social norms of cigarette and hookah smokers in Iranian universities
por: Roohafza, Hamidreza, et al.
Publicado: (2013) -
Stress as a risk factor for noncompliance with treatment regimens in patients with diabetes and hypertension
por: Roohafza, Hamidreza, et al.
Publicado: (2016) -
What Every Cardiologist Should Know about H1N1?
por: Golabchi, Allahyar, et al.
Publicado: (2010)